Clinical Trials Browser

Recruiting × INDUSTRY × peposertib × Clear all

NCT05868174 2024-05-01

Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors

Phase 1 Recruiting

GenitourinaryOther solid neoplasm

Solid Tumor, Adult